RecruitingNCT05325736

Improvement in Glycemic Response After Bariatric Surgery

Sponsor

Weizmann Institute of Science

Enrollment

120 participants

Start Date

Jul 1, 2021

Study Type

OBSERVATIONAL

Conditions

Bariatric Surgery

Summary

decipher the role of microbiota in glycemic response change after bariatric surgery

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria3

candidates of bariatric surgery or cholecystectomy
age 18-70
male/female

Exclusion Criteria7

previous bariatric surgery
type 1 diabetes
antibiotic treatment 3 months prior to the study
probiotic treatment 3 months prior to the study
chronic disease - gastrointestinal disease, malignancy, psychiatric disorder, endocrinologic disorders
any pathologic findings during endoscopy
participants who will suffer from a post-operation complication

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREsleeve gastrectomy surgery

participants undergoing sleeve gastrectomy surgery

PROCEDUREgastric bypass surgery

participants undergoing gastric bypass surgery

PROCEDUREcontrol

cholecystectomy

PROCEDUREPancreatectomy

Collecting a sample of an unidentified healthy pancreas to extract insulin-secreting beta cells from the sample

Locations(2)

Weizmann Institute of Science

Rehovot, Israel

Souraski medical center

Tel Aviv, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05325736

Related Trials

Impact of a Pro-diversity Gut Microbiota Diet After a Bariatric Surgery on Gut Microbiota, Eating Behaviour and Sensory Function

NCT072685083 locations

Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery

NCT070005391 location